Skip to main content

Sky Labs

Sky Labs' CART Ring Hits 300,000 Prescriptions, Enters Korea BP Guidelines

Image
Sky Labs' CART Ring Hits 300,000 Prescriptions, Enters Korea BP Guidelines

Munich – September 09, 2026 -- Sky Labs presented new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor, CART, achieves an approximately 80% data-usability rate in continuous 24-hour monitoring of patients with atrial fibrillation, addressing a measurement gap left by traditional cuff-based devices in patients with irregular pulse or severe blood pressure fluctuations.

Chonnam University trial confirms 24-hour monitoring feasibility in atrial fibrillation patients

Professor Ki-Hong Lee of Chonnam National University Hospital reported that CART enabled precise observation of nocturnal blood pressure dipping patterns in atrial fibrillation patients, with a data-usability rate near 80% across continuous 24-hour recordings.

Sky Labs' CART Ring Validated for AFib, Heart Failure BP Monitoring

Image
Sky Labs' CART Ring Validated for AFib, Heart Failure BP Monitoring

Munich – September 09, 2026 -- Sky Labs unveiled new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor CART achieved an 80% data evaluability rate in 24-hour monitoring of patients with atrial fibrillation (AFib), addressing a gap where conventional cuffs struggle with irregular pulses.

CART shows high concordance with standard ambulatory monitoring in severe heart failure patients

Professor In-Cheol Kim of Keimyung University Dongsan Hospital reported that CART, tested against conventional 24-hour ambulatory blood pressure monitoring (ABPM) in heart failure patients with a mean ejection fraction of 29%, showed high concordance and fully met European Society of Hypertension (ESH) error-margin criteria.

Sky Labs' CART Ring Shows 80% Data Accuracy in AFib, Heart Failure Trials

Image
Sky Labs' CART Ring Shows 80% Data Accuracy in AFib, Heart Failure Trials

Munich – September 09, 2026 -- Sky Labs presented new clinical trial data for its ring-based blood pressure monitor, CART, at the ESC Congress 2026 in Munich on September 7, showing an 80% data evaluability rate in continuous monitoring of atrial fibrillation (AFib) patients and high correlation with standard ambulatory blood pressure monitoring (ABPM) in severe heart failure cases.

CART achieves 80% evaluability rate in 24-hour monitoring of atrial fibrillation patients

Professor Ki-Hong Lee of Chonnam National University Hospital reported that CART's ring-based 24-hour monitoring achieved approximately 80% data evaluability in AFib patients, enabling continuous tracking of nocturnal blood pressure dipping patterns that irregular pulse rates typically disrupt for cuff-based devices.